Editor - Peter Kennedy | Southern General Hospital | 12412
E-ISSN: 2314-7326
P-ISSN: 2314-7334

Journal of Neuroinfectious Diseases
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 230

Journal of Neuroinfectious Diseases received 230 citations as per google scholar report

Journal of Neuroinfectious Diseases peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • Cab direct
  • Publons
  • Geneva Foundation for Medical Education and Research
Share This Page

Peter Kennedy

Peter Kennedy
Peter Kennedy Institute of Infection, Immunity and Inflammation
College of Medical, Veterinary and Life Sciences University of Glasgow Urquhart Building Garscube Campus Glasgow G61 1QH Scotland, UK    


Dr.Peter Kennedy is  Burton Chair of Neurology - Head of the Division of Clinical Neurosciences - Honorary Consultant Neurologist, Institute of Neurological Sciences, Southern General Hospital ,Dr Kennedy is President of the International Society for Neurovirology and Chairman of the Scientist Panel on Infections including AIDS of the European Federation of Neurological Societies. He is a fellow of the Academy of Medical Sciences (1998) and Fellow of the Royal Society of Edinburgh (1992).

Research Interest

African trypanosomiasis,viral factors that may determine the development of post-herpetic neuralgia,neuropathogenesis of human African trypansomiasis, also known as sleeping sickness, primarily in a mouse model of the disease, but also more recently in human patients in Uganda.



Global Speakers in the subject

Global Experts in the subject